The technology sector is doing well, especially with semiconductor stocks leading the way. Nvidia (NVDA) has gone up by 4.74%, while AMD has increased by 7.28%, thanks to strong earnings and positive forecasts. On the other hand, the healthcare sector is facing difficulties. AbbVie (ABBV) has dropped by 2.85%, and Eli Lilly (LLY) is down by 1.57% due to concerns over pricing regulations and market saturation.

Market Sentiment

Market sentiment is mixed. Tech stocks are attracting more attention, while healthcare is struggling with regulatory challenges. Currently, there’s a noticeable trend favoring growth stocks, particularly in technology. Investors should consider the momentum in tech, especially with semiconductor stocks like NVDA and AMD. It’s important to monitor healthcare regulations before making major investment decisions. Diversifying is key to managing sector volatility. Given the clear differences we’re observing, the strategy for derivatives in the upcoming weeks is becoming very specific. This isn’t just about the overall market direction; it’s more about taking advantage of the performance gap. The strong momentum in semiconductors, driven by the Santa Clara chipmaker and its main competitor, is setting up a classic scenario for bullish derivatives strategies. We’re not just looking at stock prices; explosive option volumes are emerging, particularly with short-dated calls. With a critical earnings report expected around May 22nd, we predict a significant rise in implied volatility. Historically, it has increased by over 30% in the two weeks before earnings. This makes buying naked calls quite expensive. Instead, we recommend using call debit spreads, allowing traders to take advantage of upward momentum while limiting costs and reducing the impact of post-earnings volatility.

Investment Opportunities

In contrast, the struggles in healthcare present a different but equally interesting opportunity. The pressure on companies like those from Indianapolis and their Illinois counterparts is not just market sentiment; it is influenced by real political challenges. The Congressional Budget Office has pointed out that Medicare price negotiations could decrease pharmaceutical revenues by over $25 billion annually within the next decade. This persistent pressure limits upside potential. Therefore, derivative traders might consider using put debit spreads to profit from further declines, or for those who think the worst is already reflected, selling out-of-the-money call credit spreads to gain premium as these stocks remain stagnant. Implied volatility is lower in healthcare, making bearish positions more cost-effective. What we’re essentially witnessing is a shift in capital. In just the past month, the VanEck Semiconductor ETF has gained over $1.6 billion in net inflows, while the Health Care Select Sector SPDR Fund has experienced slower growth and, at times, negative flows. This confirms that money is moving. Thus, the strategy is to leverage options to benefit from the tech surge while also capitalizing on the downturn in big pharma. It’s about being long in one sector while shorting the difficulties in another. Create your live VT Markets account and start trading now.

here to set up a live account on VT Markets now